Artemisinin antimalarials: preserving the “magic bullet”
Open Access
- 9 December 2009
- journal article
- review article
- Published by Wiley in Drug Development Research
- Vol. 71 (1) , 12-19
Abstract
The artemisinins are the most effective antimalarial drugs known. They possess a remarkably wide therapeutic index. These agents have been used in traditional Chinese herbal medicine for more than 2,000 years but were not subjected to scientific scrutiny until the 1970s. The first formal clinical trials of the artemisinins, and the development of methods for their industrial scale production, followed rapidly. A decade later, Chinese scientists shared their findings with the rest of the world; since then, a significant body of international trial evidence has confirmed these drugs to be far superior to any available alternatives. In particular, they have the ability to rapidly kill a broad range of asexual parasite stages at safe concentrations that are consistently achievable via standard dosing regimens. As their half‐life is very short, there was also thought to be a low risk of resistance. These discoveries coincided with the appearance and spread of resistance to all the other major classes of antimalarials. As a result, the artemisinins now form an essential element of recommended first‐line antimalarial treatment regimens worldwide. To minimize the risk of artemisinin resistance, they are recommended to be used to treat uncomplicated malaria in combination with other antimalarials as artemisinin combination therapies (ACTs). Their rollout has resulted in documented reductions in malaria prevalence in a number of African and Asian countries. Unfortunately, there are already worrisome early signs of artemisinin resistance appearing in western Cambodia. If this resistance were to spread, it would be disastrous for malaria control efforts worldwide. The enormous challenge for the international community is how to avert this catastrophe and preserve the effectiveness of this antimalarial “magic bullet”. Drug Dev Res 71: 12–19, 2010.Keywords
This publication has 54 references indexed in Scilit:
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- The role of mathematical modelling in malaria elimination and eradication (Comment on: Can malaria be eliminated?)Transactions of the Royal Society of Tropical Medicine and Hygiene, 2009
- The last man standing is the most resistant: eliminating artemisinin-resistant malaria in CambodiaMalaria Journal, 2009
- Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trialThe Lancet, 2009
- ORIGINAL ARTICLE: Probability of emergence of antimalarial resistance in different stages of the parasite life cycleEvolutionary Applications, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008
- Recent highlights in antimalarial drug resistance and chemotherapy researchTrends in Parasitology, 2008
- Pharmacokinetic Determinants of the Window of Selection for Antimalarial Drug ResistanceAntimicrobial Agents and Chemotherapy, 2008
- Qinghaosu (Artemisinin): The Price of SuccessScience, 2008
- Reflections on the ‘discovery’ of the antimalarial qinghaoBritish Journal of Clinical Pharmacology, 2006